Literature DB >> 24436013

In vitro effect of amphotericin B on Candida albicans, Candida glabrata and Candida parapsilosis biofilm formation.

Małgorzata Prażyńska1, Eugenia Gospodarek.   

Abstract

Candida spp. biofilm is considered highly resistant to conventional antifungals. The aim of this study was to investigate the in vitro effect of amphotericin B on Candida spp. biofilms at different stages of maturation. We investigated the activity of amphotericin B against 78 clinical isolates of Candida spp., representing three species, growing as planktonic and sessile cells, by a widely accepted broth microdilution method. The in vitro effect on sessile cell viability was evaluated by MTT reduction assay. All examined strains were susceptible to amphotericin B when grown as free-living cells. At the early stages of biofilm maturation 96.7-100.0 % strains, depending on species, displayed amphotericin B sessile minimal inhibitory concentration (SMIC) ≤ 1 μg/mL. Mature Candida spp. biofilm of 32.1-90.0 % strains displayed amphotericin B SMIC ≤ 1 μg/mL. Based on these results, amphotericin B displays species- and strain-depending activity against Candida spp. biofilms.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24436013     DOI: 10.1007/s11046-014-9727-7

Source DB:  PubMed          Journal:  Mycopathologia        ISSN: 0301-486X            Impact factor:   2.574


  27 in total

Review 1.  Bacterial biofilms: a common cause of persistent infections.

Authors:  J W Costerton; P S Stewart; E P Greenberg
Journal:  Science       Date:  1999-05-21       Impact factor: 47.728

2.  Conditions for optimal Candida biofilm development in microtiter plates.

Authors:  Bastiaan P Krom; Jesse B Cohen; Gail McElhaney-Feser; Henk J Busscher; Henny C van der Mei; Ronald L Cihlar
Journal:  Methods Mol Biol       Date:  2009

3.  Biofilm formation by the fungal pathogen Candida albicans: development, architecture, and drug resistance.

Authors:  J Chandra; D M Kuhn; P K Mukherjee; L L Hoyer; T McCormick; M A Ghannoum
Journal:  J Bacteriol       Date:  2001-09       Impact factor: 3.490

4.  Biofilm matrix of Candida albicans and Candida tropicalis: chemical composition and role in drug resistance.

Authors:  Mohammed A Al-Fattani; L Julia Douglas
Journal:  J Med Microbiol       Date:  2006-08       Impact factor: 2.472

Review 5.  Candida infections of medical devices.

Authors:  Erna M Kojic; Rabih O Darouiche
Journal:  Clin Microbiol Rev       Date:  2004-04       Impact factor: 26.132

6.  Species-specific differences in the susceptibilities of biofilms formed by Candida bloodstream isolates to echinocandin antifungals.

Authors:  Hyun Woo Choi; Jong Hee Shin; Sook In Jung; Kyung Hwa Park; Duck Cho; Seung Jung Kee; Myung Geun Shin; Soon Pal Suh; Dong Wook Ryang
Journal:  Antimicrob Agents Chemother       Date:  2007-02-05       Impact factor: 5.191

7.  Pharmacokinetics of amphotericin B and flucytosine.

Authors:  A Polak
Journal:  Postgrad Med J       Date:  1979-09       Impact factor: 2.401

8.  Variations in DNA subtype, antifungal susceptibility, and slime production among clinical isolates of Candida parapsilosis.

Authors:  M A Pfaller; S A Messer; R J Hollis
Journal:  Diagn Microbiol Infect Dis       Date:  1995-01       Impact factor: 2.803

9.  Candida albicans forms biofilms on the vaginal mucosa.

Authors:  M M Harriott; E A Lilly; T E Rodriguez; P L Fidel; M C Noverr
Journal:  Microbiology (Reading)       Date:  2010-08-12       Impact factor: 2.777

10.  Importance of biofilm in Candida parapsilosis and evaluation of its susceptibility to antifungal agents by colorimetric method.

Authors:  F Růzicka; V Holá; M Votava; R Tejkalová
Journal:  Folia Microbiol (Praha)       Date:  2007       Impact factor: 2.629

View more
  7 in total

1.  Detection and quantification of fluconazole within Candida glabrata biofilms.

Authors:  Célia F Rodrigues; Sónia Silva; Joana Azeredo; Mariana Henriques
Journal:  Mycopathologia       Date:  2015-01-23       Impact factor: 2.574

2.  Lack of efficacy of echinocandins against high metabolic activity biofilms of Candida parapsilosis clinical isolates.

Authors:  Danilo Yamamoto Thomaz; Marcia de Souza Carvalho Melhem; João Nobrega de Almeida Júnior; Gil Benard; Gilda Maria Barbaro Del Negro
Journal:  Braz J Microbiol       Date:  2020-01-02       Impact factor: 2.476

3.  Combination of Posaconazole and Amphotericin B in the Treatment of Candida glabrata Biofilms.

Authors:  Célia F Rodrigues; Diana F Alves; Mariana Henriques
Journal:  Microorganisms       Date:  2018-12-04

4.  Anti-Candida Properties of Gossypium hirsutum L.: Enhancement of Fungal Growth, Biofilm Production and Antifungal Resistance.

Authors:  Luciene Ferreira de Lima; Jacqueline Cosmo Andrade-Pinheiro; Maria Audilene Freitas; Adriely Idalina da Silva; Victor Juno Alencar Fonseca; Taís Gusmão da Silva; Josefa Carolaine Pereira da Silva; Rosilaine Honorato de Lima; Débora Lima Sales; Rejane Pereira Neves; Edy Sousa de Brito; Paulo Riceli Vasconcelos Ribeiro; Kirley Marques Canuto; Henrique Douglas Melo Coutinho; Abolghasem Siyadatpanah; Bonglee Kim; Maria Flaviana Bezerra Morais-Braga
Journal:  Pharmaceutics       Date:  2022-03-24       Impact factor: 6.525

Review 5.  Global Prevalence of Antifungal-Resistant Candida parapsilosis: A Systematic Review and Meta-Analysis.

Authors:  Dina Yamin; Mutiat Hammed Akanmu; Abbas Al Mutair; Saad Alhumaid; Ali A Rabaan; Khalid Hajissa
Journal:  Trop Med Infect Dis       Date:  2022-08-16

Review 6.  Drug repurposing strategies in the development of potential antifungal agents.

Authors:  Qian Zhang; Fangyan Liu; Meng Zeng; Yingyu Mao; Zhangyong Song
Journal:  Appl Microbiol Biotechnol       Date:  2021-06-21       Impact factor: 4.813

7.  Liposomal and Deoxycholate Amphotericin B Formulations: Effectiveness against Biofilm Infections of Candida spp.

Authors:  Célia F Rodrigues; Mariana Henriques
Journal:  Pathogens       Date:  2017-12-01
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.